Carbenoxolone does not cross the blood brain barrier: an HPLC study

Carbenoxolone does not cross the blood brain barrier: an HPLC study

<p>Abstract</p> <p>Background</p> <p>Carbenoxolone (CBX) is a widely used gap junctional blocker. Considering several reports indicating that transient gap junctional blockade could be a favourable intervention following injuries to central nervous tissue, and some curr...

Full description

Bibliographic Details
Main Authors:	Burnham William M, Perez Velazquez Jose L, Yue Wendy, Likhodii Sergei, Leshchenko Yevgen
Format:	Article
Language:	English
Published:	BMC 2006-01-01
Series:	BMC Neuroscience
Online Access:	http://www.biomedcentral.com/1471-2202/7/3

Similar Items

The biochemical pharmacology of carbenoxolone
by: Humphrey, Michael John
Published: (1972)

Some studies on the pharmacological biochemistry of carbenoxolone
by: Lindup, William Edward
Published: (1971)

RP-18 HPLC Analysis of Drugs’ Ability to Cross the Blood-Brain Barrier
by: Anna W. Sobańska, et al.
Published: (2019-01-01)

Encapsulated Carbenoxolone Reduces Lung Metastases
by: Adi Karsch-Bluman, et al.
Published: (2019-09-01)

Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.
by: Takahiro Teshima, et al.
Published: (2015-01-01)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
by: Takahiro Teshima, et al.
Published: (2016-01-01)

Effects of Intrathecal Carbenoxolone Treatment on Nociception and Analgesia in Rat
by: Marjan Kamalpour, et al.
Published: (2014-06-01)

Carbenoxolone induced depression of rhythmogenesis in the pre-Bötzinger Complex
by: VanDam Richard J, et al.
Published: (2008-05-01)

Bioadhesiveness of thiolated pectin for buccal delivery of carbenoxolone sodium
by: Kamonrak Cheewatanakornkool, et al.
Published: (2016-02-01)

Effect of glycyrrhetic acid derivative,Carbenoxolone, on the pharmacokinetics of Prednisolone
by: Der-Ren Lou, et al.
Published: (1994)

Interactions of carbenoxolone sodium with other protein-bound drugs
by: Thornton, Phillip Charles
Published: (1979)

TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice
by: Sara Crespo Yanguas, et al.
Published: (2018-03-01)

Spreading depolarization evoked by endothelin-1 is inhibited by octanol but not by carbenoxolone
by: Gabor C. Petzold, et al.
Published: (2021-03-01)

Characteristics of compounds that cross the blood-brain barrier
by: Banks William A
Published: (2009-06-01)

Pathway analysis reveals common pro-survival mechanisms of metyrapone and carbenoxolone after traumatic brain injury.
by: Helen L Hellmich, et al.
Published: (2013-01-01)

Effect of levetiracetam and carbenoxolone on epilepsy model rats and related molecular mechanism
by: Yi Jia, et al.
Published: (2016-10-01)

The Effect of Carbenoxolone and Various other Drugs upon the gastric and Duodenal Mucosae
by: Shillingford, V. S.
Published: (1975)

Blood–brain barrier opening to large molecules does not imply blood–brain barrier opening to small ions
by: E.J. Kang, et al.
Published: (2013-04-01)

Anticonvulsant, hypnotic and muscle relaxant effects of carbenoxolone, the synthetic constituent of licorice in mice
by: Asl M Nassiri, et al.
Published: (2003-03-01)

Possible strategies to cross the blood–brain barrier
by: Cinzia M. Bellettato, et al.
Published: (2018-11-01)

Crossing the Blood-Brain Barrier by Neuroinvasive Pathogens
by: Tkáčová Z., et al.
Published: (2018-03-01)

Decreased Fast Ripples in the Hippocampus of Rats with Spontaneous Recurrent Seizures Treated with Carbenoxolone and Quinine
by: Consuelo Ventura-Mejía, et al.
Published: (2014-01-01)

The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier
by: Chi-Fen Chiu, et al.
Published: (2020-02-01)

Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
by: Julien Saint-Pol, et al.
Published: (2020-04-01)

TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier
by: Shuo Yu, et al.
Published: (2019-05-01)

Carbenoxolone blocks the light-evoked rise in intracellular calcium in isolated melanopsin ganglion cell photoreceptors.
by: Jayne R Bramley, et al.
Published: (2011-01-01)

Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases
by: Małgorzata Janicka, et al.
Published: (2020-01-01)

Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
by: Victor M. Pulgar, et al.
Published: (2019-01-01)

Astrocytic gap junction inhibition by carbenoxolone enhances the protective effects of ischemic preconditioning following cerebral ischemia
by: Di Ma, et al.
Published: (2018-07-01)

The Effect of Intrathecal Administration of Carbenoxolone and Muscimol on Chemical Pain in Rats Underwent C-fiber Removal Process
by: Masoud Fereidoni, et al.
Published: (2015-07-01)

From Blood to the Brain: Can Systemically Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier?
by: Linan Liu, et al.
Published: (2013-01-01)

The blood-brain barrier
by: Robert D. Tschirgi
Published: (1958-12-01)

The blood–brain barrier
by: Alan M. Palmer
Published: (2010-01-01)

Permeability of the Blood-Brain Barrier and Transport of Nanobodies Across the Blood-Brain Barrier
by: Širochmanová I., et al.
Published: (2018-03-01)

Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
by: William M. Pardridge
Published: (2020-01-01)

Design of Nanoparticles that Cross the Blood-Brain Barrier by Receptor Mediated Transcytosis
by: Wiley, Devin Thomas
Published: (2013)

Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.
by: Sofie Stalmans, et al.
Published: (2015-01-01)

A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
by: Hernán Cortés, et al.
Published: (2020-08-01)

Zika virus crosses an in vitro human blood brain barrier model
by: Judie B. Alimonti, et al.
Published: (2018-05-01)

Food-Derived Hemorphins Cross Intestinal and Blood–Brain Barriers In Vitro
by: Dorothée Domenger, et al.
Published: (2018-04-01)